Tickerover
Financial Services

CME Stock Analysis

CME Group Inc. · current price $285.77 (+1.72% today)

Solid setup — 3/4 EPS beats, 63% net margin. Momentum, fundamentals and macro indicators are aligned.
★★★★
Quality
📊

The six-pillar scorecard

Momentum
66
Drifting higher
price trend
Growth
25
Barely growing
sales & profit growth
Quality
100
High quality
profitability & balance sheet
Valuation
10
Expensive
is the price fair?
Sentiment
40
Mixed views
analyst & crowd mood
Risk
79
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
FundamentalsFundamentals: 7171Earnings qualityEarnings quality: 7373Insider biasInsider bias: 1001001-month momentum1-month momentum: 6262Relative strengthRelative strength: 6565Trend strengthTrend strength: 8585RSI zoneRSI zone: 5555
Margin profileWhat survives each step down the income statement.
GrossGross: 100.0%100.0%OperatingOperating: 65.0%65.0%NetNet: 63.4%63.4%Free cash flowFree cash flow: 62.3%62.3%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +2.8% vs estimate+3%2026-062026-03: -25.0% vs estimate-25%2026-032025-12: +99.0% vs estimate+99%2025-122025-09: +2.0% vs estimate+2%2025-09
👁

Hype Check

Reading CME’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading CME’s filings…

📣

Latest earnings

LAST EARNINGS CME Group Inc. (CME)

Latest earnings

EPS
$2.68 vs $2.63 est · +2.0% vs estimate BEAT
Revenue
$1.71B · +11.0% YoY
Stock reaction (1M)
+7.0%
Beat streak
3 of last 4 quarters
💰

Valuation

P/E
23.8×
Forward P/E
22.1×
PEG
4.93
Price / Sales
15.2×
Price / Book
3.9×
EV / EBITDA
21.9×
Analyst target
$283.07
Target range
$230.00 – $330.00
Implied upside
-0.9%
🩺

Financial health

Gross margin
100.0%
Operating margin
65.0%
Net margin
63.4%
FCF margin
62.3%
Return on equity
15.8%
Debt / equity
0.15
Revenue growth YoY
+0.8%
EPS growth YoY
+2.5%
📈

Technicals

$218.3152-week range$329.16
RSI (14)
72
50-day MA
$253.99
200-day MA
$278.75
ATR (14)
5.80
Beta
0.27
1-month return
+7.0%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$2.68$2.63+2.0%Beat
2025-12-31$2.77$2.74+1.0%Beat
2026-03-31$3.36$3.37-0.2%Miss
2026-06-30$2.99$2.91+2.8%Beat
Beat 3 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.02%
Dividend yield
1.85%
Beta
0.27
📰

Latest news on CME

🔗

Similar stocks in Financial Services

Frequently asked

What is CME's Quant Score?

CME Group Inc. (CME) currently has a TickerMover Quant Score of 64/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is CME Group Inc. (CME) a buy?

TickerMover does not give buy or sell recommendations. CME scores 64/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is CME's score updated?

CME's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for CME →